Skip to main content

Table 3 Clinical characteristics of schizophrenia and psychiatric history in cannabis users and non-users

From: Cannabis and schizophrenia: characterisation of a risk factor in a sample of Moroccan patients hospitalised for psychosis

 

Non-users of cannabis

Cannabis users

P

Age at diagnosis, mean (SD)

30.5 (6.8)

21.2 (9,3)

0.0026

History of hospitalisation, n (%)

16 (61.5)

46 (66.6)

0.5033

Annual hospitalisations

  Average number (DS)

3.7 (2.5)

4.3 (3.3)

0.6701

  Average duration (days ± SD)

31.6 (7.8)

29.2 (6.0)

0.5428

Reasons for hospitalisation, n (%)

  

0.1037

  Behavioural problems

17 (65.3)

31 (44.9)

 

  Suicidal threat

0 (0)

7 (10.1)

 

  Addictive behaviour

3 (11.5)

16 (23.1)

 

  Psychotic relapse

20 (76.9)

58 (84.0)

 

  Other

10 (38.4)

25 (36.2)

 

Family history, n (%)

PANSS score, average (DS)

  Positive scale

18 (4.3)

39 (6.6)

 

  Negative scale

29 (7.8)

41 (8.0)

 

  General psychopathology scale

67 (12.6)

102 (13.1)

 

  Total score (/210)

104 (8.2)

181 (15.4)

0.0001

CRDPSS score, average (SD)

  Hallucinations

1 (0.0)

3 (1.6)

 

  Delusional ideas

0 (0.0)

2 (0.7)

 

  Disorganised speech

1 (1.2)

4 (0.0)

 

  Abnormal psychomotor behaviour

2 (0.3)

3 (1.2)

 

  Negative symptoms

2 (1.3)

3 (1.3)

 

  Cognitive deficit

1 (0.8)

2 (0.8)

 

  Depression

2 (1.6)

4 (0.6)

 

  Mania

1 (1.2)

3 (1.2)

 

  Total score (/32)

10 (3.4)

25 (4.7)

0.0021

  1. Under the term “Other,” we have grouped the reasons: somatic complaints, delusions, anxiety, and sudden mutism
  2. SD Standard deviation